Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Events entities : Enanta pharmaceuticals, inc. save search
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2024 Outlook at the 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-04 (Crawled : 13:30) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: 0.19%
H: 15.28%
C: 13.58%
conference pharmaceuticals research
Enanta Pharmaceuticals to Participate in Two Investor Conferences in May
Published: 2023-05-09 (Crawled : 12:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -30.09%
H: 6.83%
C: 6.33%
pharmaceuticals
Enanta Pharmaceuticals Presents Data for its COVID-19 and Respiratory Syncytial Virus Programs at the 33rd European Congress of Clinical Microbiology and Infectious Diseases
Published: 2023-04-17 (Crawled : 13:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: 0.44%
H: 5.72%
C: 3.6%
covid-19 respiratory pharmaceuticals virus
Enanta Pharmaceuticals to Present at the Oppenheimer 33rd Annual Healthcare Conference
Published: 2023-03-07 (Crawled : 14:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -0.02%
H: 2.0%
C: 0.34%
pharmaceuticals conference
Enanta Pharmaceuticals to Provide Updates on its Research and Development Programs and 2023 Outlook at the 41st Annual J.P. Morgan Healthcare Conference
Published: 2023-01-06 (Crawled : 17:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: 0.28%
H: 6.94%
C: 6.49%
pharmaceuticals research conference
Enanta Pharmaceuticals to Participate in Two Investor Conferences in November
Published: 2022-11-22 (Crawled : 13:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -9.61%
H: 10.68%
C: 8.35%
pharmaceuticals
Enanta Pharmaceuticals Presents New Preclinical Data for EDP-235, its Oral, Direct-Acting Antiviral Protease Inhibitor Specifically Designed for the Treatment of COVID-19 at IDWeek™ 2022
Published: 2022-10-19 (Crawled : 13:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -0.49%
H: 1.88%
C: -4.3%
edp-235 covid-19 treatment pharmaceuticals preclinical antiviral
Enanta Pharmaceuticals Presents Preclinical Data for its Respiratory Syncytial Virus (RSV) and Human Metapneumovirus (hMPV) Programs at the 12th International RSV Symposium
Published: 2022-09-29 (Crawled : 12:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -1.02%
H: 0.91%
C: -2.04%
pharmaceuticals preclinical symposium respiratory virus international
Enanta Pharmaceuticals Announces New Preclinical Data for its Respiratory Virology Programs to be Presented at the 12th International RSV Symposium
Published: 2022-09-22 (Crawled : 12:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -0.27%
H: 0.78%
C: 0.15%
pharmaceuticals preclinical symposium respiratory international
Enanta Pharmaceuticals to Host Conference Call on May 9 at 4:30 p.m. ET to Discuss its Financial Results for its Fiscal Second Quarter Ended March 31, 2022
Published: 2022-05-02 (Crawled : 12:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -3.67%
H: 3.09%
C: 0.09%
conference
Enanta Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare Conference
Published: 2022-01-04 (Crawled : 15:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: 0.7%
H: 0.0%
C: 0.0%
health als thc conference j.p. morgan healthcare conference
Enanta’s Oral Protease Inhibitor to be Presented at ISRIV-WHO Virtual 2021 Conference
Published: 2021-10-06 (Crawled : 14:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -0.43%
H: 2.04%
C: 1.56%
conference
Enanta Pharmaceuticals Announces Data Presentations at AASLD’s The Liver Meeting® 2021
Published: 2021-10-01 (Crawled : 12:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: 2.08%
H: 0.0%
C: 0.0%
presentation liver
Enanta Pharmaceuticals to Present Preclinical Data for EDP-721, its Novel Oral Hepatitis B Virus RNA Destabilizer, at the International Liver Congress™ 2021 Sponsored by the European Association for the Study of the Liver
Published: 2021-06-03 (Crawled : 12:00) - biospace.com/
ENTA | $13.28 0.38% 0.38% 140K
|
Health Technology
|
| O: -0.11%
H: 3.23%
C: 2.84%
hepatitis europe liver preclinical pre-clinical
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.